Citizens Financial Group’s ResMed RMD Stock Holding History

Citizens Financial Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$338K	Buy	1,735 +440	+34%	+$91.2K	﹤0.01%	801
2026 Q1	$291K	Buy	1,295 +92	+8%	+$22.9K	﹤0.01%	698
2025 Q4	$290K	Sell	1,203 -77	-6%	-$19.7K	﹤0.01%	666
2025 Q3	$350K	Buy	1,280 +155	+14%	+$42.3K	﹤0.01%	608
2025 Q2	$290K	Buy	1,125 +218	+24%	+$52K	﹤0.01%	583
2025 Q1	$203K	Buy	+907	New	+$212K	﹤0.01%	589
2020 Q3	–	Sell	-247	Closed	-$47K	–	787
2020 Q2	$47K	Sell	247 -102	-29%	-$16.7K	﹤0.01%	480
2020 Q1	$51K	Sell	349 -46	-12%	-$7.33K	﹤0.01%	425
2019 Q4	$61K	Buy	+395	New	+$56.9K	﹤0.01%	401

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citizens Financial Group's RMD Position: Q2 2026 in Review

Citizens Financial Group increased its ResMed (RMD) stake by 34% in Q2 2026, buying an estimated $91.2K and bringing the position to 1,735 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Citizens Financial Group first reported a position in RMD in Q4 2019 and has held it in 9 quarters since. The position peaked at $350K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Citizens Financial Group held 1,735 shares of ResMed worth $338K as of Q2 2026.
Citizens Financial Group bought 440 ResMed shares in Q2 2026, an estimated $91.2K.
ResMed made up ﹤0.01% of Citizens Financial Group's portfolio in Q2 2026, its #801 holding.
Citizens Financial Group first reported a position in ResMed in Q4 2019 and has held it in 9 quarters since.
Citizens Financial Group's ResMed position peaked at $350K in Q3 2025.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.